These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35086634)

  • 21. COVID-19 and tuberculosis: A mathematical model based forecasting in Delhi, India.
    Marimuthu Y; Nagappa B; Sharma N; Basu S; Chopra KK
    Indian J Tuberc; 2020 Apr; 67(2):177-181. PubMed ID: 32553309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time to regain lost ground: Tuberculosis in the COVID-19 era.
    Zenner D
    Euro Surveill; 2021 Jun; 26(24):. PubMed ID: 34142654
    [No Abstract]   [Full Text] [Related]  

  • 23. Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa.
    Nachega JB; Kapata N; Sam-Agudu NA; Decloedt EH; Katoto PDMC; Nagu T; Mwaba P; Yeboah-Manu D; Chanda-Kapata P; Ntoumi F; Geng EH; Zumla A
    Int J Infect Dis; 2021 Dec; 113 Suppl 1():S16-S21. PubMed ID: 33757874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
    Silva DR; Mello FCQ; D'Ambrosio L; Centis R; Dalcolmo MP; Migliori GB
    J Bras Pneumol; 2021; 47(2):e20210044. PubMed ID: 33950095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National TB prevalence surveys in the COVID-19 era.
    Tadolini M; Onozaki I
    Int J Tuberc Lung Dis; 2022 Jan; 26(1):4-5. PubMed ID: 34969421
    [No Abstract]   [Full Text] [Related]  

  • 26. Decline in TB incidence during the COVID-19 pandemic.
    Zamani S; Honarvar MR; Behnampour N; Sheikhy M; Sedaghat M; Ghaemi S; Ghaemi EA
    Int J Tuberc Lung Dis; 2021 Dec; 25(12):1043-1044. PubMed ID: 34886939
    [No Abstract]   [Full Text] [Related]  

  • 27. Mortality due to TB-COVID-19 coinfection in India.
    Kumar MS; Surendran D; Manu MS; Rakesh PS; Balakrishnan S
    Int J Tuberc Lung Dis; 2021 Mar; 25(3):250-251. PubMed ID: 33688819
    [No Abstract]   [Full Text] [Related]  

  • 28. Care of tuberculosis patients in the times of COVID-19.
    Tale S; Meitei Soibam P
    Indian J Tuberc; 2021 Apr; 68(2):285-286. PubMed ID: 33845968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal health coverage and tuberculosis care in India in the times of Covid-19: Aligning Ayushman Bharat (National Health Assurance Scheme) to improve case detection, reduce deaths and catastrophic health expenditure.
    Bhargava A; Bhargava M; Meher A
    Natl Med J India; 2020; 33(5):298-301. PubMed ID: 34213460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the COVID-19 pandemic on tuberculosis services.
    Palanca PA; Rodriguez-Morales AJ; Franco OH
    Int J Mycobacteriol; 2021; 10(4):478-479. PubMed ID: 34916472
    [No Abstract]   [Full Text] [Related]  

  • 31. Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy.
    Musso M; Di Gennaro F; Gualano G; Mosti S; Cerva C; Fard SN; Libertone R; Di Bari V; Cristofaro M; Tonnarini R; Castilletti C; Goletti D; Palmieri F
    Infection; 2021 Oct; 49(5):1061-1064. PubMed ID: 33454928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The aftermath of COVID-19 pandemic on the diagnosis of TB at a tertiary care hospital in India.
    Hazra D; Chawla K; Shenoy VP; Pandey AK; S N
    J Infect Public Health; 2021 Aug; 14(8):1095-1098. PubMed ID: 34274858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis and COVID-19 in India- double trouble!
    Iyengar KP; Jain VK
    Indian J Tuberc; 2020 Dec; 67(4S):S175-S176. PubMed ID: 33308667
    [No Abstract]   [Full Text] [Related]  

  • 34. TB and COVID-19: measuring key risk factors that affect treatment outcomes.
    Harries AD; Kumar AMV; Satyanarayana S; Thekkur P; Lin Y; Dlodlo RA; Brigden G
    Int J Tuberc Lung Dis; 2021 Apr; 25(4):329-331. PubMed ID: 33762081
    [No Abstract]   [Full Text] [Related]  

  • 35. Disrupted care in Papua New Guinea: the harms of COVID-19.
    McCall C
    Lancet; 2022 Jan; 399(10321):226-227. PubMed ID: 35033215
    [No Abstract]   [Full Text] [Related]  

  • 36. Challenges in TB control and the anticipated COVID-19 third wave: Way forward.
    Padmapriyadarsini C; Banurekha V; Arora VK
    Indian J Tuberc; 2021 Oct; 68(4):425-427. PubMed ID: 34752307
    [No Abstract]   [Full Text] [Related]  

  • 37. Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence.
    Tamuzi JL; Ayele BT; Shumba CS; Adetokunboh OO; Uwimana-Nicol J; Haile ZT; Inugu J; Nyasulu PS
    BMC Infect Dis; 2020 Oct; 20(1):744. PubMed ID: 33036570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria.
    Adewole OO
    Int J Tuberc Lung Dis; 2020 Sep; 24(9):981-982. PubMed ID: 33156771
    [No Abstract]   [Full Text] [Related]  

  • 39. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects.
    Visca D; Ong CWM; Tiberi S; Centis R; D'Ambrosio L; Chen B; Mueller J; Mueller P; Duarte R; Dalcolmo M; Sotgiu G; Migliori GB; Goletti D
    Pulmonology; 2021; 27(2):151-165. PubMed ID: 33547029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TB and the COVID-19 pandemic: brothers in arms against lung health.
    Shahriarirad R; Fallahi MJ
    Int J Tuberc Lung Dis; 2020 Oct; 24(10):1126-1127. PubMed ID: 33126954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.